Bob Nelsen (Photo by Michael Kovac/Getty Images)
With stars aligned and cash in reserve, Bob Nelsen's Resilience plans a makeover at 2 new facility additions to its drug manufacturing upstart
Bob Nelsen’s new, state-of-the-art drug manufacturing initiative is taking shape.
Just 3 months after gathering $800 million of launch money, a dream team board …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
